Latest Health News
WHO Director-General Calls for Increased Private Funding in Mental Health
At the Private Global Mental Health Funder Roundtable on January 19, 2026, WHO's Director-General highlighted that over one billion people live with mental health conditions, yet mental health receives only 2% of health budgets. Spending disparities are stark, from $65 per person in high-income countries to 4 US cents in low-income ones.
He urged private capital to support evidence-based systems aligned with member state priorities.
Breakthrough in Growing Helper T Cells from Stem Cells for Cancer Therapy
University of British Columbia researchers developed a method to reliably produce helper T cells from stem cells, addressing a key barrier in immune-based cancer therapies. By controlling a specific signal, they can direct stem cells to become helper or killer T cells in lab conditions suitable for biomanufacturing.
These cells function like natural ones, potentially enabling scalable, affordable treatments for cancer and other diseases.
One Year After US Aid Pause: Catastrophic Human Costs in Global Health
One year post-Trump administration's 90-day aid pause on January 20, 2025, clinics closed, medicines were stranded, and health workers lost jobs worldwide. In Somalia, malnourished child admissions to MSF facilities doubled, with deaths rising 44% in early 2025.
This signals a shift via the America First Global Health Strategy, diminishing US roles in nutrition and reproductive health.
US Set to Withdraw from WHO on January 22, 2026
The United States plans to exit the World Health Organization on January 22, 2026, potentially disrupting global health and disease surveillance. Experts warn of major consequences for international cooperation.
This follows prior aid disruptions reshaping global health engagement.
MSK Research Reveals Gut Protection Mechanisms and Glioma Macrophage Subtype
Memorial Sloan Kettering studies show how gut epithelial cells sense bacteria for protection and identify glioma-associated macrophages pivotal in tumor progression. Targeting these mGAMs could enhance immunotherapy effectiveness.
Reduced surgery is viable for some thyroid cancer patients.
Global Health EDCTP3 Allocates €147 Million for Infectious Disease Research in 2026
The Global Health EDCTP3 Joint Undertaking opened calls on January 14, 2026, for up to €147 million targeting TB, HIV, lower respiratory infections, and climate-driven diseases. Proposals due March 4, 2026, aim to bolster global health security amid funding pressures.
Past efforts supported malaria vaccines and trained 3,000+ African scientists.
£16.5 Million UK Funding for Neurodegenerative Disease Research Including Alzheimer's
University of Bristol leads SleepBoost study on slow-wave sleep's role in clearing brain proteins linked to Alzheimer's, with recruitment starting later in 2026. Other projects target cerebral small vessel disease and brain chemistry changes.
Industry collaborations accelerate translation to treatments.
Doctors Without Borders Reports Surge in Malnutrition Deaths Due to US Aid Cuts
In Somalia's Baidoa hospital, severely malnourished child deaths rose 44% in early 2025, with 47% dying within two days of arrival. Aid disruptions halted therapeutic milk shipments for months, doubling admissions.
MSF warns of ongoing shifts away from humanitarian priorities.
2026 Biopharma Trends: AI-Driven Discovery and Base Editing Advances
Industry leaders predict AI, base editing for precise gene modifications, and multiomics for personalized therapies will shape drug discovery amid economic challenges. Progress in xenotransplantation, gene therapy vectors, and in-vitro gametogenesis highlighted.
Oncology and immunology blockbusters like Keytruda continue dominating.
Health Policy Shifts Under Trump-Vance: Key Developments to Watch in 2026
US health policy faces crossroads with regulatory, legislative, and judicial changes under the Trump-Vance administration. Impacts on global health from aid cuts and WHO exit loom large.
Focus on America First strategy narrows outbreak response while sidelining NCDs.
Precision Medicine Advances: Markers for Triple-Negative Breast Cancer Detection
Four markers enable capture of triple-negative breast cancer cells in blood samples, aiding early detection. Ongoing research in pancreatic cancer and customizable protein platforms for treatment.
Bio-detection innovations like dogs for medical sniffing emerging.